Request Pricing

Global Infectious Disease Situation Update

Reporting Period: May 04-12, 2026

The AeroClenz Chief Medical Officer periodically reviews publicly available infectious disease surveillance reports from organizations such as the Centers for Disease Control and Prevention (CDC), World Health Organization (WHO), and European Centre for Disease Prevention and Control (ECDC).

These summaries are intended to provide general awareness of global infectious disease activity relevant to international travel, healthcare systems, and high-traffic indoor environments.

This information is provided for situational awareness only and does not constitute medical advice.

Key Takeaways

For the period of May 4–12, 2026, several notable global infectious disease trends were observed:

  • An Andes hantavirus outbreak linked to cruise travel emerged as a significant travel-medicine event
  • Measles continues to present a substantial disruption risk due to ongoing outbreaks and declining vaccination coverage
  • Global respiratory virus activity remains low overall
  • Cholera, chikungunya, dengue, and other travel-associated infectious diseases remain active concerns
  • High-consequence zoonotic pathogens continue to be monitored despite low current public-health risk

Top 5 Signals

1) Andes hantavirus outbreak linked to cruise travel

ECDC reports 11 total cases linked to the MV Hondius cruise ship outbreak, including 9 confirmed cases, 2 probable cases, and 3 deaths as of May 12, 2026.

The pathogen involved is Andes hantavirus, which is notable because it is the only hantavirus known to allow person-to-person transmission under certain close-contact conditions.

Public-health agencies continue to characterize overall risk to the general population as low, while emphasizing the importance of monitoring and international coordination related to the outbreak.

2) Measles remains the highest disruption risk per case

CDC reports 1,842 confirmed measles cases in the United States as of May 7, 2026, across 39 jurisdictions, with approximately 93% associated with outbreaks.

CDC also notes that MMR vaccination coverage among U.S. kindergarten populations has declined compared to pre-pandemic levels, contributing to ongoing vulnerability in some communities.

3) Respiratory virus activity remains low globally

WHO’s latest respiratory surveillance update indicates:

  • Influenza positivity below 10% globally
  • Low SARS-CoV-2 activity
  • Stable, low RSV activity

Influenza B remains the predominant circulating strain globally, while localized influenza A(H3N2) activity continues in some regions.

4) Broader surveillance activity continues across multiple pathogens

ECDC’s week 19 surveillance reporting includes ongoing monitoring of:

  • Hantavirus
  • Mpox
  • MERS-CoV
  • Salmonella Stanley
  • Respiratory virus activity across the EU/EEA

This reflects continued international focus on emerging infectious disease surveillance beyond seasonal respiratory viruses.

5) Cholera, arboviruses, and H5N1 remain relevant background risks

Cholera activity continues primarily in regions with fragile water and sanitation infrastructure.

Meanwhile:

  • Chikungunya and dengue remain relevant travel-associated risks entering warmer weather seasons
  • H5N1 avian influenza continues to be monitored as a One Health and agricultural surveillance issue rather than a routine passenger-health threat

Global Situation Overview

Andes Hantavirus and Cruise Travel

The MV Hondius outbreak represents one of the most notable travel-related infectious disease events of this reporting period.

According to ECDC, passengers and crew from more than 20 countries were associated with the event following severe respiratory illness identified aboard the vessel.

WHO reporting notes that response measures have included:

  • Clinical management
  • Contact tracing
  • Laboratory testing
  • International coordination through public-health channels

Although Andes hantavirus transmission generally requires close and prolonged contact, the outbreak highlights the complexity of international travel-associated infectious disease investigations.

Measles

Measles remains one of the most operationally significant infectious diseases due to:

  • High transmissibility
  • Amplification through travel
  • Resource-intensive contact investigations

CDC continues to emphasize that measles outbreaks are occurring globally and may spread through high-travel environments and undervaccinated populations.

Respiratory Viruses

The global respiratory disease picture continues to improve following the peak winter season.

WHO surveillance indicates:

  • Declining influenza activity
  • Low SARS-CoV-2 circulation
  • Stable, low RSV activity

While no major surge signals are currently identified, localized influenza activity remains present in several regions.

Mpox, MERS-CoV, and Foodborne Surveillance

Mpox continues to be monitored globally, with ongoing surveillance of transmission trends and clade-specific activity.

MERS-CoV remains a low-frequency but clinically important pathogen associated with travel and healthcare exposures.

Salmonella Stanley continues to be monitored as part of international foodborne illness surveillance.

Cholera and Arboviruses

Cholera remains a significant concern in regions where water, sanitation, and healthcare systems are under strain.

Arboviral diseases—including chikungunya and dengue—remain relevant travel-health considerations, particularly entering peak seasonal travel periods.

CDC continues to maintain a Level 2 travel notice for chikungunya in the Seychelles, emphasizing mosquito bite prevention and traveler awareness.

H5N1 and One Health Monitoring

CDC continues to report widespread circulation of H5N1 avian influenza among wild birds and poultry populations, with some involvement of dairy cattle and sporadic human infections.

Public-health agencies continue to assess current risk to the general population as low while maintaining ongoing surveillance related to viral evolution and occupational exposure.

Summary

The global infectious disease landscape for early May 2026 reflects improving respiratory virus trends alongside continued monitoring of travel-associated outbreaks and emerging zoonotic threats.

Key themes include:

  • The Andes hantavirus cruise-ship outbreak as a major travel-medicine event
  • Continued measles outbreak activity and declining vaccination coverage
  • Low but persistent respiratory virus circulation globally
  • Ongoing cholera and arboviral activity in affected regions
  • Continued surveillance of high-consequence and One Health pathogens

Public-health surveillance agencies continue to monitor these developments and publish updates as new information becomes available.

Sources referenced in this summary include the Centers for Disease Control and Prevention (CDC), the World Health Organization (WHO), the European Centre for Disease Prevention and Control (ECDC), and peer-reviewed literature and public-health surveillance reporting.

To learn more about AeroClenz, visit www.aeroclenz.com. Follow AeroClenz on social media for updates on research and technology developments.

LinkedIn: https://www.linkedin.com/company/aeroclenz
Facebook: https://www.facebook.com/AeroClenz
Instagram: https://www.instagram.com/aeroclenz_

Get Updates Automatically
Translate »
Scroll to Top

Michael Stroup

Chief Operations Officer

Michael is a results-driven leader with 20 years of experience improving operations to achieve greater organizational effectiveness, productivity, and performance across multiple industries. Most recently Michael served as Integration Engineering Manager at CooperSurgical, a leading fertility medical device manufacturer. Prior to CSI, he has a proven track record of driving operational and engineering excellence within medical device, food, electronics and automotive industries by leading day to day operations and providing effective strategic leadership/execution.  His expertise includes, but is not limited to, global production set up, process improvements, machinery design and compliance. Michaels holds a Bachelor of Science in Mechanical Engineering Technology and Industrial Automotive Technology from Indiana State University and a Master of Science in Industrial Technology from Indiana State University.

Matt Saberton

CEO, Founder, Co-Inventor

Matt has been passionate about aviation from a young age, earning his private pilot’s license in high school. After obtaining a degree in Aviation and Aerospace Science, he began his career as a flight instructor and then became an air ambulance pilot, where he recognized the importance of cabin cleanliness.

Rising through the ranks at one of the largest worldwide charter airlines, Matt became Captain and later Chief Pilot, gaining deep insights into maintaining safe environments in aviation. This experience led him to found Aeroclenz, Inc., where he now serves as CEO.

Under his leadership, Aeroclenz has transitioned from an aerospace-focused company to a leader in UV disinfection solutions, offering custom products for both aerospace and terrestrial indoor applications. While the company’s roots are in aviation, its technologies now ensure high standards of cleanliness across various industries.

Jameson Trettenero

Director of Marketing

Jameson is a seasoned marketing expert with experience driving strategic marketing initiatives across a diverse array of industries. In his role, Jameson leads the marketing efforts with a focus on innovative growth strategies, brand elevation, and data-driven decision-making that align with the company’s overarching business goals.

Before joining Aeroclenz, Jameson held key leadership positions at top-tier digital agencies. In his agency experience, he spearheaded multi-divisional teams across disciplines including SEO, Paid Media, Analytics, and Creative. His strategic oversight and client-centric approach significantly enhanced client retention and business growth, particularly across enterprise-level accounts.

Jameson’s expertise extends to managing complex client relationships, advising C-level executives, and navigating the intricacies of the marketing landscape. His ability to harmonize creativity with analytics has consistently driven measurable success for clients, from Fortune 500 companies to emerging brands.